Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
6.93
+0.16 (2.36%)
Mar 31, 2025, 3:47 PM EDT - Market open
Niagen Bioscience Employees
Niagen Bioscience had 104 employees as of December 31, 2024. The number of employees decreased by 2 or -1.89% compared to the previous year.
Employees
104
Change (1Y)
-2
Growth (1Y)
-1.89%
Revenue / Employee
$957,663
Profits / Employee
$82,212
Market Cap
539.97M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NAGE News
- 11 days ago - Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide Riboside (NR) Salt Forms - Business Wire
- 12 days ago - ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision Science - Business Wire
- 18 days ago - ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025 - Business Wire
- 19 days ago - ChromaDex to Present at the 37th Annual Roth Conference - Business Wire
- 25 days ago - ChromaDex Capitalizes On Longevity Boom But Valuation Remains High - Seeking Alpha
- 26 days ago - ChromaDex Corporation (CDXC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 26 days ago - ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results - Business Wire
- 4 weeks ago - ChromaDex to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 4, 2025 - Business Wire